Aratana Therapeutics Inc. (PETX) Drops 6.38% on February 19

Equities Staff |

Aratana Therapeutics Inc. (PETX) was one of the Russell 2000's biggest losers for Friday February 19 as the stock slid 6.38% to $3.08, a loss of $-0.21 per share. Starting at an opening price of $3.26 a share, the stock traded between $3.04 and $3.26 over the course of the trading day. Volume was 385,676 shares over 2,578 trades, against an average daily volume of 566,979 shares and a total float of 35.01 million.

The losses send Aratana Therapeutics Inc. down to a market cap of $107.82 million. In the last year, Aratana Therapeutics Inc. has traded between $20.63 and $2.56, and its 50-day SMA is currently $4.25 and 200-day SMA is $10.84.

Aratana Therapeutics Inc is a development-stage biopharmaceutical company. It is engaged in licensing, development and commercialization of prescription medicines for companion animals.

Aratana Therapeutics Inc. is based out of Kansas City, KS and has some 60 employees. Its CEO is Steven Peter.

For a complete fundamental analysis analysis of Aratana Therapeutics Inc., check out’s Stock Valuation Analysis report for PETX. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Nano One Materials Corp.

Nano One Materials Corp is a technology company. The Company manufactures storage materials for lithium ion batteries.

Private Markets

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…